DexCom Statistics

Total Valuation

DexCom has a market cap or net worth of GBP 27.62 billion. The enterprise value is 27.70 billion.

Market Cap	27.62B
Enterprise Value	27.70B

Important Dates

The next estimated earnings date is Thursday, February 6, 2025.

Earnings Date	Feb 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-2.90%
Shares Change (QoQ)	-1.58%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	387.69M

Valuation Ratios

The trailing PE ratio is 54.38.

PE Ratio	54.38
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	20.02
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 39.05, with an EV/FCF ratio of 69.40.

EV / Earnings	54.53
EV / Sales	8.63
EV / EBITDA	39.05
EV / EBIT	54.32
EV / FCF	69.40

Financial Position

The company has a current ratio of 2.46, with a Debt / Equity ratio of 1.31.

Current Ratio	2.46
Quick Ratio	2.03
Debt / Equity	1.31
Debt / EBITDA	2.97
Debt / FCF	4.84
Interest Coverage	33.05

Financial Efficiency

Return on equity (ROE) is 32.06% and return on invested capital (ROIC) is 8.21%.

Return on Equity (ROE)	32.06%
Return on Assets (ROA)	6.06%
Return on Capital (ROIC)	8.21%
Revenue Per Employee	308,909
Profits Per Employee	53,188
Employee Count	9,600
Asset Turnover	0.61
Inventory Turnover	2.60

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.86% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-31.86%
50-Day Moving Average	78.08
200-Day Moving Average	92.35
Relative Strength Index (RSI)	70.95
Average Volume (20 Days)	3,492

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.19

Income Statement

In the last 12 months, DexCom had revenue of GBP 2.95 billion and earned 507.94 million in profits. Earnings per share was 1.24.

Revenue	2.95B
Gross Profit	1.82B
Operating Income	468.55M
Pretax Income	555.02M
Net Income	507.94M
EBITDA	627.02M
EBIT	468.55M
Earnings Per Share (EPS)	1.24

Full Income Statement

Balance Sheet

The company has 1.86 billion in cash and 1.93 billion in debt, giving a net cash position of -73.79 million.

Cash & Cash Equivalents	1.86B
Total Debt	1.93B
Net Cash	-73.79M
Net Cash Per Share	n/a
Equity (Book Value)	1.48B
Book Value Per Share	3.78
Working Capital	1.89B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 613.07 million and capital expenditures -213.91 million, giving a free cash flow of 399.16 million.

Operating Cash Flow	613.07M
Capital Expenditures	-213.91M
Free Cash Flow	399.16M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 61.68%, with operating and profit margins of 15.88% and 17.22%.

Gross Margin	61.68%
Operating Margin	15.88%
Pretax Margin	18.81%
Profit Margin	17.22%
EBITDA Margin	21.25%
EBIT Margin	15.88%
FCF Margin	13.53%

Dividends & Yields

DexCom does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.90%
Shareholder Yield	2.90%
Earnings Yield	1.84%
FCF Yield	1.45%

Stock Splits

The last stock split was on June 13, 2022. It was a forward split with a ratio of 4.

Last Split Date	Jun 13, 2022
Split Type	Forward
Split Ratio	4

Scores

DexCom has an Altman Z-Score of 7.59.

Altman Z-Score	7.59
Piotroski F-Score	n/a